Getty ImagesNEW DELHI: Shares of Ltd. traded 0.53 per cent up in Tuesday's trade at 11:48AM (IST). Around 18,051 shares changed hands on the counter.
The stock opened at Rs 977.9 and touched an intraday high and low of Rs 979.95 and Rs 968.65, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1023.1 and a 52-week low of Rs 605.05.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 57131.94 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 6498.31 crore for the quarter ended 31-Dec-2020, down 0.59 per cent from previous quarter's Rs 6537.19 crore and down 9.66 per cent from the year-ago quarter's Rs 5925.93 crore.
The net profit for latest quarter stood at Rs 2946.46 crore, up 317.67 per cent from the same quarter a year ago.
As of 31-Mar-2021, DIIs held 8.84 per cent stake in the company, while foreign institutional investors held 26.62 per cent and the promoters 51.94 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 10.61 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
The stock opened at Rs 977.9 and touched an intraday high and low of Rs 979.95 and Rs 968.65, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1023.1 and a 52-week low of Rs 605.05.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 57131.94 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 6498.31 crore for the quarter ended 31-Dec-2020, down 0.59 per cent from previous quarter's Rs 6537.19 crore and down 9.66 per cent from the year-ago quarter's Rs 5925.93 crore.
The net profit for latest quarter stood at Rs 2946.46 crore, up 317.67 per cent from the same quarter a year ago.
Shareholding pattern
As of 31-Mar-2021, DIIs held 8.84 per cent stake in the company, while foreign institutional investors held 26.62 per cent and the promoters 51.94 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 10.61 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
